Gilead Sciences stock falls after earnings beat, revenue miss
October 24, 2019 at 16:21 PM EDT
Gilead Science Inc. shares dropped about 2.5% in the extended session Thursday, after the drug maker beat Wall Street’s earnings expectations but reported lower-than-expected sales.
